戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 130457作成日:2026年10月27日

3-(Methoxymethyl)benzeneboronic acid → N-[5-(cis-3,5-Dimethyl-1-piperazinyl)-2-(methyloxy)phenyl]-5-{3-[(methyloxy)methyl]phenyl}-2-thiophenesulfonamide

https://huagongshe.com/reaction/130457

反応式

関与物質

役割名称HCID仕込み量
反応物3-(Methoxymethyl)benzeneboronic acidHCID 3825855—
反応物Potassium tert-butoxideHCID 23665647—
反応物5-Bromo-N-[5-(cis-3,5-dimethyl-1-piperazinyl)-2-(methyloxy)phenyl]-2-thiophenesulfonamideHCID 59007058—
触媒HCID 178418397HCID 178418397—
溶媒WaterHCID 962—
溶媒1,2-DimethoxyethaneHCID 8071—
生成物N-[5-(cis-3,5-Dimethyl-1-piperazinyl)-2-(methyloxy)phenyl]-5-{3-[(methyloxy)methyl]phenyl}-2-thiophenesulfonamideHCID 59007093—

反応条件

温度100 °C

反応手順

To a mixture of 5-bromo-N-[5-(cis-3,5-dimethyl-1-piperazinyl)-2-(methyloxy)phenyl]-2-thiophenesulfonamide (E122) (100 mg, 0.22 mmol) and {3-[(methyloxy)methyl]phenyl}boronic acid (83 mg, 0.5 mmol) in DME (3 ml) was added potassium tert-butoxide (210 mg, 1.9 mmol) and tetrakis(triphenylphosphine)palladium(0) (15 mg, 0.013 mmol) in water (1 ml) and the resulting mixture stirred in a microwave (set at high absorbance) at 100° C. for 30 minutes. The resulting mixture was then concentrated in Genevac and residues passed over SCX. Basic fractions were re-concentrated in Genevac and the residue purified using mass directed autoprep HPLC to afford the title compound (E123). MS (ES+) m/e 502 [M+H]+.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US07381728B2
出典データセットuspto-grants-2008_06
ORD IDord-4c6e2ccf7dda44938fab0b983311ce43
出典メモuspto-grants-2008_06